JP Morgan Maintains Overweight on ESAB, Lowers Price Target to $95

Benzinga Newsdesk www.benzinga.com Negative 60.8%

Neg 60.8% Neu 0% Pos 0%

JP Morgan analyst Tami Zakaria maintains ESAB (NYSE:ESAB) with a Overweight and lowers the price target from $125 to $95.